Correction: Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications
Arthritis Res Ther
.
2023 Jan 23;25(1):11.
doi: 10.1186/s13075-023-02993-0.
Authors
Fatima El-Adili
1
2
3
,
Justin K Lui
4
,
Mortada Najem
1
,
Giuseppina Farina
1
3
,
Maria Trojanowska
1
3
,
Flora Sam
2
,
Andreea M Bujor
5
6
Affiliations
1
Division of Rheumatology, Boston University School of Medicine, Boston, MA, USA.
2
Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA.
3
Arthritis and Autoimmune Diseases Center, Boston University, 72 E Concord St, Evans 501, Boston, MA, 02118, USA.
4
The Pulmonary Center, Boston University School of Medicine, Boston, MA, USA.
5
Division of Rheumatology, Boston University School of Medicine, Boston, MA, USA. andreea@bu.edu.
6
Arthritis and Autoimmune Diseases Center, Boston University, 72 E Concord St, Evans 501, Boston, MA, 02118, USA. andreea@bu.edu.
PMID:
36691037
PMCID:
PMC9869504
DOI:
10.1186/s13075-023-02993-0
No abstract available
Publication types
Published Erratum
Grants and funding
R01 AR042334/AR/NIAMS NIH HHS/United States